CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 360 enrolled
Drug / intervention
Colchicinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03021343
NCT03021343Phase 3Completed
CompareCT.gov

Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial

Jordan Collaborating Cardiology Group·interventional·Posted Jan 13, 2017·Updated Jan 23, 2018

In Brief

A Phase 3 clinical trial evaluating Colchicine for Arrhythmia. Completed, enrolled 360 participants.

Detailed Summary

This study evaluates the role of colchicine in the prevention of atrial fibrillation in patients undergoing open heart surgery. Half of participants will receive colchicine and the other half will not

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 13, 2017
Enrollment StartOct 1, 2012
Primary CompletionJan 1, 2015
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.5 years ago

Interventions

Colchicinedrug

colchicine given as per trial protocol